[Chromosomal resistance of plague agent to quinolones]. 1991

I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia

The nature of increasing chromosomal resistance to quinolones was studied in a model of the plague microbe. Five virulent strains of the natural plague microbe (Y. pestis) were used in the experiment: 363 (1/1479), 231, 2385, 2442 and 2444. The one-stage procedure for isolation of the mutants was applied. It was shown that the frequency of the one-stage mutants resistant to oxalinic acid, pefloxacin and ciprofloxacin amounted to 10(-9)-10(-11) and was 2 to 3 orders of magnitude lower than that of the mutants resistant to nalidixic acid. Two types of the plague microbe mutants resistant to the quinolones were detected: those resistant to the quinolones to the generations (Nalr-phenotype) and those resistant to the representatives of the 3rd generation quinolones (Nals-phenotype). The quinolones were not efficient in the treatment of albino mice with experimental plague caused by the quinolone-resistant forms of the plague microbe.

UI MeSH Term Description Entries
D008957 Models, Genetic Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Genetic Models,Genetic Model,Model, Genetic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010930 Plague An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form. Bubonic Plague,Meningeal Plague,Pneumonic Plague,Pulmonic Plague,Black Death,Black Plague,Septicemic Plague,Yersinia pestis Infection
D002876 Chromosomes, Bacterial Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell. Bacterial Chromosome,Bacterial Chromosomes,Chromosome, Bacterial
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015010 Yersinia pestis The etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents. Bacillus pestis,Bacterium pestis,Pasteurella pestis,Pestisella pestis,Yersinia pseudotuberculosis subsp. pestis
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
December 1987, Pharmaceutisch weekblad. Scientific edition,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
January 1993, Drugs,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
January 1992, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
July 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
January 1996, Research in microbiology,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
October 1996, Nihon saikingaku zasshi. Japanese journal of bacteriology,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
March 2002, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
January 1993, Drugs,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
January 2005, Enfermedades infecciosas y microbiologia clinica,
I V Kasatkina, and A I Shcherbaniuk, and L N Makarovskaia, and E N Padeĭskaia
January 2001, Veterinary research,
Copied contents to your clipboard!